Cargando…
MCL-1 Inhibition by Selective BH3 Mimetics Disrupts Mitochondrial Dynamics Causing Loss of Viability and Functionality of Human Cardiomyocytes
MCL-1 is a well-characterized inhibitor of cell death that has also been shown to be a regulator of mitochondrial dynamics in human pluripotent stem cells. We used cardiomyocytes derived from human-induced pluripotent stem cells (hiPSC-CMs) to uncover whether MCL-1 is crucial for cardiac function an...
Autores principales: | Rasmussen, Megan L., Taneja, Nilay, Neininger, Abigail C., Wang, Lili, Robertson, Gabriella L., Riffle, Stellan N., Shi, Linzheng, Knollmann, Bjorn C., Burnette, Dylan T., Gama, Vivian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155208/ https://www.ncbi.nlm.nih.gov/pubmed/32283523 http://dx.doi.org/10.1016/j.isci.2020.101015 |
Ejemplares similares
-
Coupling to substrate adhesions drives the maturation of muscle stress fibers into myofibrils within cardiomyocytes
por: Taneja, Nilay, et al.
Publicado: (2020) -
Low carbohydrate diet prevents Mcl-1-mediated resistance to BH3-mimetics
por: Rubio-Patiño, Camila, et al.
Publicado: (2016) -
A simple and flexible high-throughput method for the study of cardiomyocyte proliferation
por: Neininger, Abigail C., et al.
Publicado: (2019) -
First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
por: Besbes, S, et al.
Publicado: (2015) -
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
por: Zhang, Shengzhe, et al.
Publicado: (2018)